Association between neurite metrics and tau/inflammatory pathology in Alzheimer's disease

被引:24
作者
Sone, Daichi [1 ,2 ,3 ]
Shigemoto, Yoko [1 ,3 ,4 ]
Ogawa, Masayo [1 ]
Maikusa, Norihide [1 ]
Okita, Kyoji [1 ]
Takano, Harumasa [1 ]
Kato, Koichi [1 ]
Sato, Noriko [4 ]
Matsuda, Hiroshi [1 ,3 ]
机构
[1] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Tokyo, Japan
[2] UCL Inst Neurol London, Dept Clin & Expt Epilepsy, London, England
[3] Southern Tohoku Res Inst Neurosci, Cyclotron & Drug Discovery Res Ctr, Fukushima, Japan
[4] Natl Ctr Neurol & Psychiat, Dept Radiol, Tokyo, Japan
关键词
Alzheimer's disease; molecular imaging; neurodegeneration; neuroinflammation; orientation dispersion and density imaging; tau; ORIENTATION DISPERSION; TAU; MATTER; TANGLE; NODDI; MODEL;
D O I
10.1002/dad2.12125
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The molecular mechanism of neurodegeneration, including tau and neurite complexity, is an important topic in Alzheimer's disease (AD) research. Methods: We recruited 27 amyloid-positive individuals identified through C-11-Pittsburgh compound B (PiB) positron emission tomography (PET) and 31 amyloid-negative individuals with normal cognition. All participants underwent C-11-PiB and F-18-THK5351 PET and magnetic resonance imaging (MRI) with neurite orientation dispersion and density imaging (NODDI) protocol. The neurite density index (NDI), orientation dispersion index (ODI), and PET images were analyzed to calculate voxel-wise correlations among the imaging modalities and correlations with cognitions. Results: In the amyloid-positive participants, there were significant negative correlations between F-18-THK5351 and NDI and between F-18-THK5351 and ODI. The bilateral mesial and lateral temporal lobes were mainly involved. Regarding cognition, F-18-THK5351 showed more marked associations with all cognitive domains than the other modalities. Discussion: Tau and neuroinflammation in AD may reduce the neurite density and orientation dispersion, particularly in the mesial and lateral temporal lobes.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Hierarchical Distribution of the Tau Cytoskeletal Pathology in the Thalamus of Alzheimer's Disease Patients
    Rueb, Udo
    Stratmann, Katharina
    Heinsen, Helmut
    Del Turco, Domenico
    Ghebremedhin, Estifanos
    Seidel, Kay
    den Dunnen, Wilfred
    Korf, Horst-Werner
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2016, 49 (04) : 905 - 915
  • [42] Relationship between tau, neuroinflammation and atrophy in Alzheimer's disease: The NIMROD study
    Su, Li
    Surendranathan, Ajenthan
    Huang, Yujing.
    Bevan-Jones, William R.
    Passamonti, Luca
    Hong, Yong T.
    Arnold, Robert
    Rodriguez, Patricia Vazquez
    Wang, Yi
    Mak, Elijah
    Fryer, Tim D.
    Aigbirhio, Franklin
    Rowe, James B.
    O'Brien, John T.
    [J]. INFORMATION FUSION, 2021, 67 : 116 - 124
  • [43] Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease
    Colgan, N.
    Siowa, B.
    O'Callaghan, J. M.
    Harrison, I. F.
    Wells, J. A.
    Holmes, H. E.
    Ismail, O.
    Richardson, S.
    Alexander, D. C.
    Collins, E. C.
    Fisher, E. M.
    Johnson, R.
    Schwarz, A. J.
    Ahmed, Z.
    O'Neill, M. J.
    Murray, T. K.
    Zhang, H.
    Lythgoe, M. F.
    [J]. NEUROIMAGE, 2016, 125 : 739 - 744
  • [44] Immunotherapy for Targeting Tau Pathology in Alzheimer's Disease and Tauopathies
    Rosenmann, Hanna
    [J]. CURRENT ALZHEIMER RESEARCH, 2013, 10 (03) : 217 - 228
  • [45] Relationships Between Tau and Glucose Metabolism Reflect Alzheimer's Disease Pathology in Cognitively Normal Older Adults
    Adams, Jenna N.
    Lockhart, Samuel N.
    Li, Lexin
    Jagust, William J.
    [J]. CEREBRAL CORTEX, 2019, 29 (05) : 1997 - 2009
  • [46] 18F-labeled benzimidazopyridine derivatives for PET imaging of tau pathology in Alzheimer's disease
    Kaide, Sho
    Watanabe, Hiroyuki
    Shimizu, Yoichi
    Tatsumi, Haruka
    Iikuni, Shimpei
    Nakamoto, Yuji
    Togashi, Kaori
    Ihara, Masafumi
    Saji, Hideo
    Ono, Masahiro
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (16) : 3587 - 3594
  • [47] No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples
    Crawford, F
    Freeman, M
    Town, T
    Fallin, D
    Gold, M
    Duara, R
    Mullan, M
    [J]. NEUROSCIENCE LETTERS, 1999, 266 (03) : 193 - 196
  • [48] An update on the association between traumatic brain injury and Alzheimer's disease: Focus on Tau pathology and synaptic dysfunction
    Li, Liangping
    Liang, Jiawen
    Fu, Hongjun
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 120 : 372 - 386
  • [49] Fibrinogen-tau Aggregates Exacerbate Tau Pathology and Memory Deficits in Alzheimer's Disease Model Mice
    Wen, Tingting
    Meng, Lanxia
    Liu, Han
    Zhang, Qian
    Dai, Lijun
    Huang, Liqin
    Dan, Liang
    Zhu, Kedong
    Luo, Jiaying
    Zhang, Zhaohui
    [J]. NEUROSCIENCE BULLETIN, 2025,
  • [50] Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer’s disease
    Sanaz Arezoumandan
    Sharon X. Xie
    Katheryn A. Q. Cousins
    Dawn J. Mechanic-Hamilton
    Claire S. Peterson
    Camille Y. Huang
    Daniel T. Ohm
    Ranjit Ittyerah
    Corey T. McMillan
    David A. Wolk
    Paul Yushkevich
    John Q. Trojanowski
    Edward B. Lee
    Murray Grossman
    Jeffrey S. Phillips
    David J. Irwin
    [J]. Acta Neuropathologica, 2022, 144 : 1103 - 1116